Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-043219
Filing Date
2019-07-25
Accepted
2019-07-25 16:11:15
Documents
2
Period of Report
2019-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1588
2 POA DOCUMENT poa.txt EX-24.3_866016 3033
  Complete submission text file 0001209191-19-043219.txt   6220
Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Gallagher Carol Giltner (Reporting) CIK: 0001329959 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38871 | Film No.: 19974566

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations